9-95508364-TGCCGCC-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000264.5(PTCH1):c.-9_-4delGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,163,744 control chromosomes in the GnomAD database, including 127 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0091 ( 11 hom., cov: 22)
Exomes 𝑓: 0.014 ( 116 hom. )
Consequence
PTCH1
NM_000264.5 5_prime_UTR
NM_000264.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.30
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-95508364-TGCCGCC-T is Benign according to our data. Variant chr9-95508364-TGCCGCC-T is described in ClinVar as [Likely_benign]. Clinvar id is 193070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-95508364-TGCCGCC-T is described in Lovd as [Likely_benign]. Variant chr9-95508364-TGCCGCC-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00908 (1343/147830) while in subpopulation SAS AF= 0.0139 (66/4750). AF 95% confidence interval is 0.0129. There are 11 homozygotes in gnomad4. There are 574 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1343 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCH1 | NM_000264.5 | c.-9_-4delGGCGGC | 5_prime_UTR_variant | 1/24 | ENST00000331920.11 | NP_000255.2 | ||
PTCH1 | NM_001083603.3 | c.199-1771_199-1766delGGCGGC | intron_variant | ENST00000437951.6 | NP_001077072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH1 | ENST00000331920.11 | c.-9_-4delGGCGGC | 5_prime_UTR_variant | 1/24 | 5 | NM_000264.5 | ENSP00000332353.6 | |||
PTCH1 | ENST00000437951.6 | c.199-1771_199-1766delGGCGGC | intron_variant | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes AF: 0.00910 AC: 1345AN: 147724Hom.: 11 Cov.: 22
GnomAD3 genomes
AF:
AC:
1345
AN:
147724
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0141 AC: 21AN: 1492Hom.: 0 AF XY: 0.0174 AC XY: 15AN XY: 862
GnomAD3 exomes
AF:
AC:
21
AN:
1492
Hom.:
AF XY:
AC XY:
15
AN XY:
862
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0137 AC: 13923AN: 1015914Hom.: 116 AF XY: 0.0135 AC XY: 6505AN XY: 480676
GnomAD4 exome
AF:
AC:
13923
AN:
1015914
Hom.:
AF XY:
AC XY:
6505
AN XY:
480676
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00908 AC: 1343AN: 147830Hom.: 11 Cov.: 22 AF XY: 0.00797 AC XY: 574AN XY: 72028
GnomAD4 genome
AF:
AC:
1343
AN:
147830
Hom.:
Cov.:
22
AF XY:
AC XY:
574
AN XY:
72028
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 31, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 04, 2021 | - - |
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PTCH1: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 30, 2016 | Variant summary: c.-9_-4delGGCGGC affects mildly conserved nucleotides, resulting in a deletion of 6 nucleotides in the 5UTR region. This variant was found in 17/5008 control chromosomes of 1000Gs project at a frequency of 0.0034, which greatly exceeds the maximal expected frequency of a pathogenic allele (0.000017). The variant has been reported as Likely Benign by one reputable databases/clinical laboratories without evidence to independently evaluate. Taking together, the variant was classified as Benign. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2015 | Co-occurence with mutation in same gene (phase unknown);In silico models in agreement (benign);Other data supporting benign classification - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at